He studied Biochemistry at the University of Tübingen (1981-1988). Doctoral Thesis at the Institute of Chemistry and Pharmacy of the University of Tübingen (1988-1991). Post doc at the University of Rome (1991-1993). He joins Merck Research Laboratories in 1993 where he was Project Director Oncology, Chair of Early Development Team and member of the Oncology Corporate Licensing Committee. He contributed to several preclinical projects in the areas of virology and oncology, the development of one launched oncology drug and clinical stage oncology projects. He is co-author of more than 90 publications in journals such as Nature Medicine, Nature Cell Biology and PNAS and co-inventor of 12 patents or patent applications.
She studied Biology at the University of Rome, “La Sapienza” (1978-1984) obtaining the degree of Dr. in Biological Sciences with an experimental thesis at the Institute of Cellular Biology, C.N.R., Rome (1981-1984). Postdoctoral period (1984-1986) in the Department of Virology at the Istituto Superiore di Sanita’, Rome. Postdoctoral Associate in the Laboratory of Molecular Biology at The Rockefeller University (HHMI), New York (1987-1990). Group leader (1990-2001) in the Biochemistry and Oncology Departments at Merck Research Laboratories, thereafter Project leader until 2009. Co-author of more than 50 publications in journals such as Science, Nature, Nature Medicine, Nature Cell Biology and PNAS, and co-inventor of 6 patents or patent applications.
She obtained her degree in biology from the University of Rome “La Sapienza” and her PhD in Cell Biology from the University of Rome “Tor Vergata”. She starts her career at Merck & Co in 2000 as scientist in virology and oncology, to become Group Leader and Laboratory Head in Oncology. She is co-author of 14 publications in journals such as EMBO J and PNAS and 2 patents.